首页> 外文期刊>Molecular Biology >Expression and characterization of a multivalent human respiratory syncytial virus protein
【24h】

Expression and characterization of a multivalent human respiratory syncytial virus protein

机译:多价人类呼吸道合胞病毒蛋白的表达和鉴定

获取原文
获取原文并翻译 | 示例
       

摘要

Respiratory syncytial virus (RSV) has been recognized as one of the most common causes of severe respiratory tract infection in infants worldwide. As yet, a safe and effective vaccine has not been developed to protect humans from RSV. The F and G surface proteins have been widely investigated due to their potential to induce protective immunity. In addition, the M2 protein has been shown to be important in inducing a T-cell response. Our project involved the cl oning of the immunodominant regions of the RSV F, M2 and G proteins into a bacterial vector, pET-32a(+). The recombinant RFM2G protein was expressed in Escherichia coli and purified using His Bind columns. The purified rRFM2G protein was analyzed by poly-acrylamide gel electrophoresis and Western blotting. The predicted structure of the recombinant protein built by the Swiss PDB Viewer program suggested a rod shape with a distinct swollen head and neck which was confirmed by transmission electron microscopy and atomic force microscopy. BALB/c female mice were immunized with either RSV, rRFM2G alone, or rRFM2G in combination with flagellin as a mucosal adjuvant. Serum was collected on days 0, 14, 28 and 49 to assess the immune response by Enzyme-linked immunosorbent assay. Intranasal immunization of mice with the rRFM2G protein yielded significantly high serum IgG titers. Co-administration of the rRFM2G protein with flagellin did not augment the serum antibody response.[PUBLICATION ABSTRACT]
机译:呼吸道合胞病毒(RSV)已被公认为全世界婴儿严重呼吸道感染的最常见原因之一。迄今为止,尚未开发出安全有效的疫苗来保护人类免受RSV感染。由于F和G表面蛋白具有诱导保护性免疫的潜力,因此已被广泛研究。另外,已显示M2蛋白在诱导T细胞应答中很重要。我们的项目涉及将RSV F,M2和G蛋白的免疫优势区域克隆到细菌载体pET-32a(+)中。重组RFM2G蛋白在大肠杆菌中表达,并使用His Bind柱纯化。通过聚丙烯酰胺凝胶电泳和Western印迹分析纯化的rRFM2G蛋白。由Swiss PDB Viewer程序构建的重组蛋白的预测结构表明杆形具有明显的头颈部肿胀,这已通过透射电子显微镜和原子力显微镜得到了证实。用RSV,单独的rRFM2G或rRFM2G结合鞭毛蛋白作为粘膜佐剂免疫BALB / c雌性小鼠。在第0、14、28和49天收集血清以通过酶联免疫吸附测定评估免疫应答。用rRFM2G蛋白对小鼠进行鼻内免疫可显着提高血清IgG滴度。 rRFM2G蛋白与鞭毛蛋白的共同给药不会增强血清抗体应答。[出版物摘要]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号